These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31740405)

  • 1. Selective inhibition of PKR improves vascular inflammation and remodelling in high fructose treated primary vascular smooth muscle cells.
    Kalra J; Mangali S; Bhat A; Jadhav K; Dhar A
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165606. PubMed ID: 31740405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imoxin attenuates high fructose-induced oxidative stress and apoptosis in renal epithelial cells via downregulation of protein kinase R pathway.
    Kalra J; Mangali SB; Bhat A; Dhar I; Udumula MP; Dhar A
    Fundam Clin Pharmacol; 2018 Jun; 32(3):297-305. PubMed ID: 29430716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High fructose and streptozotocin induced diabetic impairments are mitigated by Indirubin-3-hydrazone via downregulation of PKR pathway in Wistar rats.
    Udumula MP; Mangali S; Kalra J; Dasari D; Goyal S; Krishna V; Bollareddy SR; Sriram D; Dhar A; Bhat A
    Sci Rep; 2021 Jun; 11(1):12924. PubMed ID: 34155273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKR inhibitor imoxin prevents hypertension, endothelial dysfunction and cardiac and vascular remodelling in L-NAME-treated rats.
    Kalra J; Dasari D; Bhat A; Mangali S; Goyal SG; Jadhav KB; Dhar A
    Life Sci; 2020 Dec; 262():118436. PubMed ID: 32950570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High glucose impairs insulin signaling via activation of PKR pathway in L6 muscle cells.
    Udumula MP; Babu MS; Bhat A; Dhar I; Sriram D; Dhar A
    Biochem Biophys Res Commun; 2017 May; 486(3):645-651. PubMed ID: 28322789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological evaluation of novel PKR inhibitor indirubin-3-hydrazone in-vitro in cardiac myocytes and in-vivo in wistar rats.
    Udumula MP; Bhat A; Mangali S; Kalra J; Dhar I; Sriram D; Dhar A
    Life Sci; 2018 Sep; 209():85-96. PubMed ID: 30076923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of protein kinase R protects against palmitic acid-induced inflammation, oxidative stress, and apoptosis through the JNK/NF-kB/NLRP3 pathway in cultured H9C2 cardiomyocytes.
    Mangali S; Bhat A; Udumula MP; Dhar I; Sriram D; Dhar A
    J Cell Biochem; 2019 Mar; 120(3):3651-3663. PubMed ID: 30259999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of double stranded RNA dependent protein kinase (PKR) abrogates isoproterenol induced myocardial ischemia in vitro in cultured cardiomyocytes and in vivo in wistar rats.
    Mangali S; Bhat A; Dasari D; Sriram D; Dhar A
    Eur J Pharmacol; 2021 Sep; 906():174223. PubMed ID: 34081906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Protein Kinase R by C16 Protects the Retinal Ganglion Cells from Hypoxia-induced Oxidative Stress, Inflammation, and Apoptosis.
    Alsabaani N
    Curr Eye Res; 2021 May; 46(5):719-730. PubMed ID: 33026257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specific PKR inhibitor C16 prevents apoptosis and IL-1β production in an acute excitotoxic rat model with a neuroinflammatory component.
    Tronel C; Page G; Bodard S; Chalon S; Antier D
    Neurochem Int; 2014 Jan; 64():73-83. PubMed ID: 24211709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of PKR pathway mediates glucolipotoxicity induced diabetic cardiomyopathy in vivo in wistar rats and in vitro in cultured cardiomyocytes.
    Mangali S; Bhat A; Jadhav K; Kalra J; Sriram D; Vamsi Krishna Venuganti V; Dhar A
    Biochem Pharmacol; 2020 Jul; 177():113948. PubMed ID: 32251680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celastrol attenuates hypertension-induced inflammation and oxidative stress in vascular smooth muscle cells via induction of heme oxygenase-1.
    Yu X; Tao W; Jiang F; Li C; Lin J; Liu C
    Am J Hypertens; 2010 Aug; 23(8):895-903. PubMed ID: 20414191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoring mitochondrial biogenesis with metformin attenuates β-GP-induced phenotypic transformation of VSMCs into an osteogenic phenotype via inhibition of PDK4/oxidative stress-mediated apoptosis.
    Ma WQ; Sun XJ; Wang Y; Zhu Y; Han XQ; Liu NF
    Mol Cell Endocrinol; 2019 Jan; 479():39-53. PubMed ID: 30170182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of double-stranded RNA-dependent protein kinase prevents oxytosis and ferroptosis in mouse hippocampal HT22 cells.
    Hirata Y; Iwasaki T; Makimura Y; Okajima S; Oh-Hashi K; Takemori H
    Toxicology; 2019 Apr; 418():1-10. PubMed ID: 30817950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Small Molecule Indirubin-3'-Oxime Inhibits Protein Kinase R: Antiapoptotic and Antioxidant Effect in Rat Cardiac Myocytes.
    Udumula MP; Medapi B; Dhar I; Bhat A; Desai K; Sriram D; Dhar A
    Pharmacology; 2016; 97(1-2):25-30. PubMed ID: 26571010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT1 requirement for PKR-induced cell cycle arrest in vascular smooth muscle cells in response to heparin.
    Handy I; Patel RC
    Gene; 2013 Jul; 524(1):15-21. PubMed ID: 23597922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of double-stranded RNA-activated protein kinase toward antiproliferative actions of heparin on vascular smooth muscle cells.
    Patel RC; Handy I; Patel CV
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1439-44. PubMed ID: 12231563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
    Chen J; Zhang J; Xu L; Xu C; Chen S; Yang J; Jiang H
    Atherosclerosis; 2012 Oct; 224(2):332-9. PubMed ID: 22857898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular pathways triggered by the selective FLT-1-agonist placental growth factor in vascular smooth muscle cells exposed to hypoxia.
    Bellik L; Vinci MC; Filippi S; Ledda F; Parenti A
    Br J Pharmacol; 2005 Oct; 146(4):568-75. PubMed ID: 16086034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.